Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
This study has been completed.
Study NCT00502775 Information provided by GlaxoSmithKline
First Received: July 17, 2007 Last Updated: August 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Allergic Rhinitis
Hayfever
Additional conditions recognized in this trial
Rhinitis
Rhinitis, Allergic, Seasonal
More general conditions related to this trial
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
fluticasone furoate, fexofenadine
Additional drug interventions recognized in this trial
Fexofenadine
Fluticasone
Terfenadine
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Dermatologic Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline
Back to top of Main Content
